CIK 0001833214 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
SAB Biotherapeutics, Inc.
Sign in to watch- Ticker
- SABS
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 853899721
- Phone
- 305-845-2813
- Business address
- 777 W 41ST ST, SUITE 401, MIAMI BEACH, FL, 33140
- Former names
- Big Cypress Acquisition Corp.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 16 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-12-07 | Spragens Jeffrey G Director | Grant or award · Warrant (Common Stock) | +82,987 | 82,987 | ||
| 2022-12-07 | Link David Charles Director | Grant or award | +41,493 | $1.21 | $50K | 57,313 |
| 2022-12-07 | Link David Charles Director | Grant or award · Warrant (Common Stock) | +41,493 | 41,493 | ||
| 2022-09-13 | Reich Samuel J Executive Chairman | Grant or award · Employee Stock Option (right to buy) | +525,000 | 525,000 | ||
| 2022-09-13 | Sullivan Eddie Joe CHIEF EXECUTIVE OFFICER | Grant or award · Employee Stock Option (right to buy) | +35,000 | 35,000 | ||
| 2022-09-13 | Giberson Scott Director | Grant or award · Employee Stock Option (right to buy) | +25,000 | 25,000 | ||
| 2022-09-13 | Kropotova Alexandra Chief Medical Officer | Grant or award · Employee Stock Option (right to buy) | +18,325 | 18,325 | ||
| 2022-09-13 | Bausch Christoph Lawrence CHIEF OPERATING OFFICER | Grant or award · Employee Stock Option (right to buy) | +274,875 | 274,875 | ||
| 2022-09-13 | Beyer Russell P CHIEF FINANCIAL OFFICER | Grant or award · Employee Stock Option (right to buy) | +274,875 | 274,875 | ||
| 2022-09-13 | HAMILTON CHRISTINE E Director | Purchase | +10,000 | $0.73 | $7K | 4,993,090 |
| 2022-09-07 | Sullivan Eddie Joe CHIEF EXECUTIVE OFFICER | Purchase | +14,000 | $0.74 | $10K | 5,230,564 |
| 2022-06-06 | Kropotova Alexandra Chief Medical Officer | Grant or award | +300,000 | 300,000 | ||
| 2022-05-20 | Spragens Jeffrey G Director | Other acquisition | +299,002 | 312,002 | ||
| 2022-05-20 | Reich Samuel J Executive Chairman | Other disposition | −2,500,127 | 547,698 | ||
| 2022-05-20 | Reich Samuel J Executive Chairman | Other acquisition | +207,001 | 208,001 | ||
| 2022-03-16 | Sullivan Eddie Joe Chief Executive Officer | Grant or award · Employee Stock Option (right to buy) | +21,218 | 21,218 | ||
| 2022-03-16 | Beyer Russell P Chief Financial Officer | Grant or award · Employee Stock Option (right to buy) | +6,000 | 6,000 | ||
| 2022-03-16 | Luke Thomas Charles Chief Medical Officer | Grant or award · Employee Stock Option (right to buy) | +20,519 | 20,519 | ||
| 2022-03-16 | Finnegan Frederick Chief Business Officer | Grant or award · Employee Stock Option (right to buy) | +23,453 | 23,453 | ||
| 2022-03-16 | Reich Samuel J Executive Chairman | Grant or award · Employee Stock Option (right to buy) | +7,000 | 7,000 |
Page 6 of 9 · 172 trades